Vertex Pharma (VRTX) Tops Q4 EPS by 6c
Tweet
Share
E-mail
Get Alerts VRTX Hot Sheet
Price: $528.04 +6.03%
Revenue Growth %: +8.4%
Financial Fact:
Restructuring expense: 8K
Today's EPS Names:
PKE, LNN, More
Revenue Growth %: +8.4%
Financial Fact:
Restructuring expense: 8K
Today's EPS Names:
PKE, LNN, More
Join SI Premium – FREE
Vertex Pharma (NASDAQ: VRTX) reported Q4 EPS of $0.35, $0.06 better than the analyst estimate of $0.29. Revenue for the quarter came in at $458.71 versus the consensus estimate of $453.4 million.
For earnings history and earnings-related data on Vertex Pharma (VRTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Lockheed Martin frontrunner for $3.5B Ultra Maritime deal, sources say - FT
- Pembina joins proposed 1M bbl/day Alberta-to-coast pipeline plan
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
